Low Nuclear Proliferative Activity Is Associated With Nonmetastatic Islet Cell Tumors
Open Access
- 1 February 2003
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 127 (2) , 196-199
- https://doi.org/10.5858/2003-127-196-lnpaia
Abstract
Context.—Traditional morphologic features of tumor aggression are of limited value in predicting the malignant behavior of endocrine neoplasms. We explored the potential value of nuclear proliferative activity (using Ki-67 immunostaining with semiquantitative scoring) in predicting the clinical behavior of pancreatic islet cell tumors (ICTs), and we correlated this characteristic with hormone expression. Objective.—To evaluate whether Ki-67 immunostaining using a semiquantitative scoring system has value in predicting the clinical behavior of pancreatic ICTs. Design.—We studied 39 pancreatic ICTs from 39 patients. Twenty-two ICTs did not metastasize in a median follow-up period of 91 months. The remaining 17 neoplasms did produce metastases (8 in liver, 7 in regional lymph nodes, and 2 in peritoneum). Immunohistochemistry was performed using antibodies to Ki-67 and pancreatic hormones (insulin, glucagon, gastrin, somatostatin, pancreatic polypeptide, vasoactive intestinal polypeptide, and corticotropin). A semiquantitative Ki-67 grading system was followed. The nuclear proliferative activity, as determined by a positive reaction for Ki-67, was considered low (25% of cells staining positively). Results.—The majority of the nonmetastatic ICTs (16 cases, 73%) demonstrated either negative or low staining for Ki-67 (P < .001). Conversely, all metastatic ICTs expressed at least an intermediate-grade reaction. High nuclear proliferative activity was only seen in metastatic neoplasms (3 cases, 17%). There was no relationship between immunoexpression of pancreatic hormones and nuclear proliferative activity by either group of tumors. Conclusion.—An ICT with low nuclear proliferative activity is unlikely to metastasize, whereas high proliferative activity is associated with a metastatic phenotype. Immunohistochemical assessment of Ki-67 using a semiquantitative scoring system is a simple and reliable detection method of cellular proliferative activity in ICTs of the pancreas.Keywords
This publication has 17 references indexed in Scilit:
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literatureEuropean Journal of Surgical Oncology, 1997
- Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variablesHuman Pathology, 1996
- Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCAVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Nucleolar organizer regions and glycoprotein‐hormone α‐chain reaction as markers of malignancy in endocrine tumours of the pancreasHistopathology, 1993
- Immunodetection of Proliferating Cell Nuclear Antigen Assesses the Growth Fraction and Predicts Malignancy in Endocrine Tumors of the PancreasThe American Journal of Surgical Pathology, 1992
- Proliferative activity of neuroendocrine tumours of the gastroenteropancreatic endocrine system: DNA flow cytometric and immunohistological investigations.Gut, 1991
- Oncoprotein immunoreactivity in human endocrine tumoursThe Journal of Pathology, 1991
- Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissuesHuman Pathology, 1990
- Pancreatic Endocrine TumorsPathology - Research and Practice, 1988